DV
Dividend Vision

CLYM — Climb Bio Inc

Climb Bio Inc (CLYM)

Total return is 2.7% over the past 5 years, 84.9 points behind SPY at 87.6%. Its deepest 1-year drawdown was 33.9%.

# Summary Limited information is available for this fund. Based on available data, this appears to be an equity stock fund that launched in August 2021. Key metrics including distribution frequency, yield, expense ratio, and assets under management are not currently available. Without complete fund documentation and objective details, it is not possible to determine its specific dividend strategy or suitability for income-focused investors.

CLYM key facts

Asset type
Stock
Asset class
Equity
Inception date
08/10/2021
Last close
$16.33
Market cap
$727,240,384
Average volume
2498243.0
Beta
0.075
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.77